Results 81 to 90 of about 16,017 (247)
A human‐in‐the‐loop Bayesian optimization framework for constraint‐aware bioprocess development
Abstract We present Pareto Front Guided Sampling (PFGS), a human‐in‐the‐loop (HiL) Bayesian Optimization (BO) framework that reformulates surrogate‐model predictions as a multi‐objective optimization problem, allowing domain knowledge to be added intuitively to any BO problem.
Samuel Stricker +6 more
wiley +1 more source
Paediatric development of radiopharmaceutical imaging agents and radioligand therapeutics
Abstract This review focuses on the development of radiopharmaceutical imaging agents and radioligand therapeutics for paediatric use. Nuclear medicine plays an important role in the diagnosis and treatment of various childhood conditions, including cancers, infections and brain disorders.
Justin L. Hay +5 more
wiley +1 more source
The recent impact of the Biopharmaceutics Classification System (BCS) and the Biopharmaceutics Drug Disposition Classification System (BDDCS) on relevant scientific advancements is discussed.
Charalabidis, Aggelos, +3 more
core +2 more sources
Silymarin and Silybin: Rejuvenating Traditional Remedies with Modern Delivery Strategies
Silymarin, a polyphenolic flavonolignan complex extracted from Silybum marianum (milk thistle), has long been recognized for its hepatoprotective, antioxidant, anti-inflammatory, and anticancer properties.
Xiuyan Li +6 more
doaj +1 more source
Nitrosylated high density lipoprotein is recognized by a scavenger receptor in rat liver.
In order to assess the presence of specific recognition sites for high density lipoprotein (HDL) in vivo, HDL was nitrosylated with tetranitromethane and the decay and liver uptake were compared with that of native HDL.
M F Kleinherenbrink-Stins +5 more
doaj +1 more source
Abstract Aim The aim of this study was to assess the general and product‐specific experiences of MAHs use of RWD/RWE in medicines development and in their regulatory submissions, and to explore organizational aspects of MAHs related to RWD/RWE. Methods An electronic survey was conducted, and information collected directly from MAHs.
Sini M. Eskola +5 more
wiley +1 more source
Aim Londamocitinib (AZD4604) is an inhaled, selective Janus kinase 1 (JAK1) inhibitor in development for asthma. This open‐label, two‐part, phase I clinical study (NCT06157255) used a radiolabelled microtracer approach to evaluate the absolute bioavailability and the absorption, distribution, metabolism and excretion (ADME) of inhaled londamocitinib ...
Camille Riff +12 more
wiley +1 more source
Aims Elecoglipron (AZD5004/ECC5004) is an oral small‐molecule glucagon‐like peptide‐1 receptor agonist (GLP‐1 RA) in development for weight management in people living with obesity or overweight and type 2 diabetes. This study aimed to characterize the pharmacokinetics (PK) profiles of two formulations of elecoglipron under fed and fasted conditions ...
Jianfeng Xu +13 more
wiley +1 more source
What Makes an “Ideal” Cell Line for Recombinant Adeno‐Associated Virus Production?
Several host cell types have been used to produce rAAVs to date. Cell line‐specific traits that are beneficial in the context of rAAV manufacturing are reviewed here, with the goal of developing a consensus on the ‘ideal’ characteristics that an rAAV production host should possess (created with Biorender.com).
James Conheady +6 more
wiley +1 more source
BIOPHARMACEUTICS AND DRUG ABSORPTION ENHANCEMENT APPROACHES
Biopharmaceutics examines how a drug’s properties, formulation variables, and physiological conditions together influence its absorption and overall bioavailability. Many new drug molecules show poor solubility, limited membrane permeability, degradation
Sakshi Patil +4 more
core +1 more source

